Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Illinois officials say Bears still may stay despite team statement
More than 60% of Minnesota high-risk Medicaid providers fail review
Senate sends $70B bill funding ICE, border patrol to vacant House
Chicago Bears to advance stadium project in Indiana
Greer, Carr commended for seeking fairness in EU treatment of US tech firms
Illinois quick hits: Pritzker pauses data center tax credits
U.S. adds 172k jobs in ‘strong’ May report, unemployment remains at 4.3%
Colorado governor vetoes legislation allowing ICE to be sued
Ballots processed slowly as Californians await 36-day count
WATCH: WA mayor stands by pro-ICE, anti-Antifa proclamations
U.S. House narrowly passes bill to fund USDA, FDA in 2027
Military advocates concerned about active-duty voters